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Abstract  Congenital  long  QT  syndrome  (cLQTS)  is  a  channelopathy  characterized  by  ventricu-
lar repolarization  disturbances.  The  clinical  presentation  varies  from  an  asymptomatic  patient
to a  patient  with  recurrent  syncopes,  seizures,  and even  sudden  death.  This  article  aims  to  con-
tribute to  medical  knowledge  of  this  relatively  new  disease  in newborns,  so that  early  diagnoses
with timely  treatments  can  be made.  Genotypically,  there  are  13  types  of  cLQTS,  which  are
classified  by  phenotype  into:  Romano-Ward,  Jervell-Lange-Nielsen,  Andersen-Tawil  and  Timo-
thy. We  present  the  following  case  of  a  newborn  who  presented  clinical  sustained  bradycardia
on her  first  day  of  life,  who  was  admitted  to  the Neonatal  Intensive  Care,  where  her  assessment
and imaging  studies  guided  us  to  a  cLQTS  diagnosis.  The  patient  recovered  satisfactorily,  and
was discharged  with  outpatient  follow-up  without  complications.
All abnormal  QT  patients  should  be assessed  with  an  integral  clinical  report,  Holter  ana-
lyzer, and  a  stress  test.  Ideally,  a  genetic  screening,  which  can  have a  great  impact  on the
treatment,  should  be  done.  Although  it  is relatively  uncommon,  recognition  of  this  entity  is
important because  it  can prevent  death.  We  present  a  case  of  cLQTS  diagnosis,  with  approach
and treatment.
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reserved.
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Introduction
Neonatal  arrhythmias  represent  a relatively  common  prob-
lem  encountered  by  pediatricians.  However,  because  most
of  them turn  out  to  be benign,  it is  vital to  master the  diag-
nostic  approach  which  allows  the identification  of  patients
who  may  be at  risk  of  death.1 cLQTS  is  a  rare  genetic  entity
from  the denominated  channelopathies,  characterized  by
http://dx.doi.org/10.1016/j.rmu.2014.07.001
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Table  1  List  of  medications  which  prolong  the  QT  interval.
Amantadine
Azithromycin/erythromycin
Chloral  hydrate
Ciprofloxacin
Cisapride
Domperidone
Furosemide
Metronidazole
Trimethoprim/Sulfamethoxazole
The University of Health Sciences Center http://www.qtdrugs.
org/.
mutations  in  ion channels  or  their  regulatory  proteins.  It may
lead  to sudden  death  because  of  ventricular  repolarization
alterations,  which is  seen  in an electrocardiogram  as  a long
QT.2
This  alteration  is  the  main  cause  of  sudden  death  in
children;  this  is  secondary  to  a  malignant  ventricular  tachy-
cardia  (torsade  de  pointes),  and  can  be  often  be  provoked
by  a  series  of  conditions,  including  sudden  noise,  expo-
sure  to  cold environments,  REM  sleep,  apnea,  leading  a
chemoreceptor  reflex  and  excitement.  It  is  also  important
to  obtain  a  detailed  family  history  and pay  special  attention
to  sudden  deaths,  ventricular  ectopic  beats  and seizures,
since  these  may  be  present  in up  to  35%  of the  seizures
induced  by  long  QT  and could  be  mistaken  for  other  causes
of  seizures.3 Long  QT  acts  as an arrhythmogenic  substrate,
in  other  words,  it  requires  a  trigger  for  the development  of
life-threatening  arrhythmias,  like  catecholamines  or  med-
ications  which  delay  QT  intervals  even  more.  Examples  of
these  medications  are listed  in Table  1.  A genetic  study  in
all  patients  with  said  electrocardiographic  alteration  must
be  performed.4 We  present  a clinical  case  of a newborn  with
an  abnormal  QT  prolongation.
Clinical  case
Newborn  without  any  important  hereditary-family  history,
full  term  (38.6 weeks),  delivered  via  C-section  due  to  pelvic
presentation.  The  baby  only required  the initial steps  of
reanimation,  with  an Apgar  score  of  8/9.  A  newborn  rou-
tine  was  performed  registering  a  weight  of 3180  g,  49  cm
in  length  and  a  head circumference  of  34  cm.  However,  a
few  hours  after  she  was  born,  we  detected  an 80  beat-per-
minute  bradycardia;  therefore,  we  decided  to  admit  her  to
the  Neonatal  Intensive  Care  Unit  (NICU).  During  physical
examination  we  recorded  a  heart  rate  of  74  beats-per-
minute,  a  respiratory  rate  of  54  breaths  per  minute,  blood
pressure  of  70/60  mm  Hg  and  SaO2 of 96%.  The  following
dysmorphias  were  found:  Head  with  wide  forehead,  wide
nasal  bridge,  low-implanted  ears, thin  upper  lip,  enlarged
philtrum  and  micrognathia;  extremities  with  clinodactyly  in
the  5th  bilateral  finger  and  bilateral  transverse  crease;  skin
with  superficial  scaling  on  the  face  and scalp,  in  addition  to
eczematous  lesions  in the  cheeks.  The  rest  of  the physical
examination  was  normal.
The  admission  tests,  such  as  biochemical  profile,  serum
electrolytes  and complete  blood  count  showed  no  alter-
ations,  as  was  the  case  for  thoracic  X-rays  too.  The  ECG
Figure  1  ECG  tracing  where  the  sinus  rythym  is shown  using
Bazett’s formula  and  finding  an  extension  of  corrected  QT.
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Figure  2 Calculation  of  the  corrected  QT  interval.
showed  sinus  bradycardia  and  we  measured  the  QT  using  the
Bazzet  formula  finding  a long  QT  in  0.46  s  (Figs. 1  and  2).
The  patient  was  referred  to  Pediatric  Cardiology  where
they  performed  an echocardiogram,  reporting  a permeable
foramen  ovale  of  2 mm without  hemodynamic  repercussion
and  performed  Holter  monitoring  presenting  non-sustained
sinus  bradycardia  with  a minimum  HR  of  58  (bpm)  and
alternating  T  waves.  With  this  data,  we  integrated  a
sinus  bradycardia  with  long  QT  diagnosis  and  we  per-
formed  consults  with  the Genetics  Service  who  suspected
Andersen--Tawil  syndrome.  The  patient  received  treatment
with  beta-blockers  (propranolol  3  mg/kg/day  orally  divided
into  three  doses)  evolving  to be hemodynamically  stable
without  presenting  bradycardias.  We  considered  a  discharge
after  13  days  of  life  outside  the womb.
Discussion
Channelopathies  are the main  cause  of  congenital  arrhyth-
mias.  They  are clinical  entities  in which  there  is  a  mutation
of  the  genes  that  control  the formation  of transmembrane
protein  responsible  for  regulating  the  amount  of  ions that  go
through  the  cell.5 cLQTS  is  the first channelopathy  described
and  it is  currently  considered  the  most  studied.  It  is  char-
acterized  by  a ventricular  affectation  of  the  repolarization
phase  and  can cause  sudden  death  by  polymorph  ventricular
tachycardia  or  Torsade  de  Pointes.6 It  was  first  described  in
1957  by  Anton  Jervell  and  Fred  Lange  Nielsen,  who  linked
a  syndrome  characterized  by  congenital  deafness,  syncope
and  sudden  deaths  with  abnormal  prolongation  of the QT
interval.  Later,  in 1964,  Romano  and Ward  observed  similar
clinical  characteristics  but  without  deafness.
Documento descargado de http://www.elsevier.es el 24-08-2016
48  I.  Rodríguez-Balderrama  et al.
Clinical  presentation  varies from  the asymptomatic
patient,  to  the  patient  with  recurrent  syncopes,  seizure
crises  and  even  sudden  death.  Its  incidence  is  1/5000
cases.7,8 To  this  day,  over  500  mutations  have  been  iden-
tified,  distributed  in 10  genes.  Genotypically,  there  are
13  types  of  cLQTS,  and  by  phenotype,  and  they  can  be
classified  into  four different  ways:  Romano-Ward,  Jervell-
Lange-Nielsen,  Andersen-Tawil  and Timothy.9
Corrected  QT  interval  measurement  was  obtained
using  Bazett’s  formula,  dividing  the  QT  interval  by  the
square  root  of  the RR  interval  (cQT  =  QT/
√
RR) ideally
in  the  V5  or  DII  derivations.  In  diagnostic  orientation
Schwartz’s  score  takes  into  account  electrocardiographic
findings,  family  history  and  pathological  background  like
syncopes.10
In this  clinical  case  we  phenotypically  describe  minor
facial  dysmorphias  such  as:  A wide  forehead,  low-implanted
ears,  a  thin  upper  lip  and  micrognathia,  in addition  to
clinodactyly  in the  5th  bilateral  finger,  which fits  better
in  a  description  of  cLQTS  7  or  Andersen  Tawil.  This  syn-
drome  currently  is  considered  to  be  a  different  entity  by
many  authors.  It is  an autosomal  dominant  alteration,  pre-
dominant  in  females  and  phenotypically  characterized  by
clinodactyly,  hypertelorism,  wide  forehead  and  low ear
implantation.  Periodic  paralysis,  abnormal  skeletal  devel-
opment  and  ventricular  arrhythmias  may  occur.  Patients
tend  to  be  asymptomatic,  or  minimally  symptomatic  despite
having  frequent  extrasystoles  or  ventricular  tachycardia,
typically  bidirectional  or  polymorphous.11
The  beta-blockers,  which  have  been  used for  over 30
years,  reduce  global  mortality  from  73%  to  6%.  Currently,
all  patients  diagnosed  with  cLQTS,  with  or  without  clini-
cal  symptoms,  must  receive  beta-blocker  treatment,  and
in  addition  the  patients  are advised  to  avoid  rigorous  physi-
cal  activity  and  administration  of  medications  which prolong
repolarization  (Table  1).  In  patients  with  high  sudden-death
risk  an  implantable  automatic  defibrillator  (IAD)  must  be
prescribed.  Within  this  group  we  included  patients  who
were  symptomatic  despite  beta-blocker  treatment,  patients
with  auriculo-ventricular  blocks,  those  with  documented
ventricular  tachycardia  in torsade  de  pointes,  and  those
patients  resuscitated  from  sudden  death.  It should  also
be  prescribed  in patients  with  an excessively  long  cQT
(≥0.5  s)  and  when there  is  a family  history  of  sudden
deaths.12
Aside  from  the diagnostic  suspicion  to  which  phenotypic
features  may  lead  us,  all  abnormal  corrected  QT  patients
must  be  approached  with  a careful  clinical  history,  and
Holter  monitoring.  We  recommend  a  follow-up  by  cardiolo-
gists  and  geneticists,  and  ideally,  a  genetic  screening,  which
can  have  an  impact  on  treatment  according  to  the  mutations
found.
Conclusion
The  importance  of  this  case  is to  create  awareness  in
the medical  community  of  these  new  pathologies  which
represent  some  of the  most important  causes  of  neona-
tal  arrhythmias;  however,  this  information,  in  addition  to
clinical  history,  would  be of  assistance  to  keep  in mind
in  these entities,  thus having  early  diagnosis  and  treat-
ment,  avoiding  death.  Moreover,  we  stress  the  importance
of  complementing  it with  geneticists  in order  to  make  better
decisions  with  the families.  Even  though  cLQTS  is  relatively
rare,  to  recognize  this entity  is  of great  importance,  because
early  intervention  and  treatment  can  avoid  the patient’s
sudden  death.
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